Adaptive Biotechnologies Corporation (ADPT) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Adaptive Biotechnologies Corporation, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -41.41x | -5.53x | -3.14x | -5.44x | -19.00x | -53.06x |
| P/B Ratio | 11.26x | 4.35x | 2.29x | 2.35x | 6.52x | 10.44x |
| P/S Ratio | 8.90x | 4.93x | 4.15x | 5.88x | 25.52x | 78.86x |
| Profitability | ||||||
| Gross Margin | 74.2% | 59.7% | 55.6% | 68.7% | 68.1% | 77.1% |
| Operating Margin | -20.6% | -90.8% | -133.3% | -108.0% | -135.4% | -155.3% |
| Net Margin | -21.5% | -89.1% | -132.3% | -108.0% | -134.3% | -148.6% |
| EBITDA Margin | -10.8% | -71.9% | -111.2% | -94.6% | -125.3% | -146.7% |
| Liquidity | ||||||
| Current Ratio | 3.34x | 2.89x | 4.66x | 5.12x | 3.54x | 6.91x |
| Quick Ratio | 3.23x | 2.81x | 4.50x | 4.99x | 3.37x | 6.78x |
| Leverage | ||||||
| Debt/Equity | 1.28x | 0.44x | 0.32x | 0.23x | 0.19x | 0.15x |
YoY = year-over-year change. Source: FMP..